-- The NEW Official Alizyme Thread! --

Still here with large holding.This company is now needing a rerating to show its results from Cetilistat and it the deal making potential.

At this price any number of bids from hopefuls are going to happen.It is thought Takeda will have first refusal.They know Alizyme and Cetilistat very well and enjoy very good relations.Do they buy the company or just Cetilistat.To take on the ww rights with the company only having a market cap of 230m does not make sense.Why pay milestone payments for 2 years of 220m for ww rights when there is every chance of taking the company for 400m and getting Col Pred and Renzipride to.Others are thinking this.A deal will happen.

Palmer is dissapointed with share price as are the investors at 1.00 in the last fund raising.Everything that the due to happen has happened and the price is DOWN on a year ago.